Tumor Dendritic Cells (DCs) Derived from Precursors of Conventional DCs Are Dispensable for Intratumor CTL Responses

por Diao, Jun, Gu, Hongtao, Tang, Michael, Zhao, Jun, Cattral, Mark S.
Publicado en J Immunol (2018)

T cell activation is reduced by the catalytically inactive form of protein tyrosine phosphatase SHP-2

por Dong, Baoxia, Gao, Yubo, Zheng, Xuan, Gao, Guangxun, Gu, Hongtao, Chen, Xiequn, Zhang, Jinyi
Publicado en Int J Clin Exp Med (2015)

Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway

por Jin, Yulong, Xu, Li, Wu, Xiaodong, Feng, Juan, Shu, Mimi, Gu, Hongtao, Gao, Guangxun, Zhang, Jinyi, Dong, Baoxia, Chen, Xiequn
Publicado en Oncol Res (2019)

Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis

por Wang, Jianhong, Duan, Xiaohui, Yang, Lijie, Liu, Xiangxiang, Hao, Caixia, Dong, Hongjuan, Gu, Hongtao, Tang, Hailong, Dong, Baoxia, Zhang, Tao, Gao, Guangxun, Liang, Rong
Publicado en Cell Transplant (2020)